22-hydroxycholesterol has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lecanu, L; Papadopoulos, V | 1 |
1 review(s) available for 22-hydroxycholesterol and Alzheimer Disease
| Article | Year |
|---|---|
Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties.
Topics: Alzheimer Disease; Animals; Brain; Caproates; Diosgenin; Drug Discovery; Humans; Hydroxycholesterols; Neurons; Rats; Spirostans | 2012 |